Cardiovascular
Myocardial Protection
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Myocardial Protection is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed10 · 63%
Unknown status4 · 25%
Recruiting1 · 6%
Terminated1 · 6%
Clinical Trials
Trial Activity
16 trials
Pediatric Myocardial Protection With Potassium Cardioplegia
Completed·—·Phase 2·NCT03229980·87 enrolled
Myocardial Protection and Anesthetic Agents
Completed·—·Phase 4·NCT02405689·60 enrolled
Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients
Completed·MMeshalkin Research Institute of Pathology of Circulation·Phase 3·NCT02757443·120 enrolled
Remote Preconditioning and Myocardial Protection
Completed·—·Phase 2·NCT02877238·91 enrolled
Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Cold Blood Cardioplegia for Myocardial Protection for Fallot Tetralogy Patients Undergoing Total Repair
Unknown status·—·Phase 1·NCT05176782·52 enrolled
Desflurane-induced Myocardial Protection
Unknown status·—·Phase 4·NCT02019797·50 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)